Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Learn about the link between type 2 diabetes and chronic kidney disease for Black Americans, key risk factors, and prevention strategies to protect kidney health.

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Anemia is common in patients who have both heart failure and chronic kidney disease, and there is an association between anemia and progression of both diseases. The main causes of anemia are ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to heart problems in diabetes patients with chronic kidney disease.